Date Field | Doc. No. | Party | Description |
---|
Aug 22, 2018 | 2024 | | Comparison of Claims 1-15 of U.S. 9,833,419 and U.S. 9,724,310 Download |
Aug 22, 2018 | 2023 | | J. van de Sandt et al., In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study, 39 REG. TOXICOL. PHARMACOL. 271¿¿¿281 (2004) Download |
Aug 22, 2018 | 2021 | | R. Subedi et al., Formulation and in vitro evaluation of transdermal drug delivery system for donezil, 42 J. PHARMA. INVEST. 1-7 (2012) Download |
Aug 22, 2018 | 2020 | | R. Subedi et al., Influence of formulation variable in transdermal drug delivery system containing zolmitriptan, 419 INT'L J. PHARMACEUTICS 209-214 (2011) Download |
Aug 22, 2018 | 2019 | | J. Bond & B. Barry, Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin, 90(6) J. INVEST. DERMATOL. 810-813 (1988) Download |
Aug 22, 2018 | 2018 | | R. Hinz et al., In vitro percutaneous penetration: evaluation of the utility of hairless mouse skin, 93(1) J. INVEST. DERMATOL. 87-91 (1989) Download |
Aug 22, 2018 | 2017 | | B. Godin & E. Touitou, Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models, 59(11) ADV. DRUG DELIV. REVIEWS 1152-1161 (2007) Download |
Aug 22, 2018 | 2016 | | U.S. Patent No. 8,029,820 Download |
Aug 22, 2018 | 2015 | | A. Ghosh et al., Current Pharmaceutical Design on Adhesive Based Transdermal Drug Delivery Systems, 21 CURR. PHARM. DESIGN 2771-2783 (2015) Download |
Aug 22, 2018 | 2014 | | Google Scholar search results obtained March 7, 2018 ¿¿¿ citations of Kim et al., Penetration Enhancement of ¿¿2-Selective Agonist, Tulobuterol, Across Hairless Mouse Skin, J. Pharm. Invest. 33: 79-84 (2003) Download |
Aug 22, 2018 | 2013 | | K. Walters & K. Brain, Dermatological Formulation and Transdermal Systems, in DERMATOLOGICAL AND TRANSDERMAL FORMULATIONS 338-43 (K. Walters, ed., 2002) Download |
Aug 22, 2018 | 2012 | | A. Williams & B. Barry, The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs, 74 INT'L J. PHARMACEUTICS 157-168 (1991) Download |
Aug 22, 2018 | 2011 | | A. Williams & B. Barry, Chemical Permeation Enhancement, in ENHANCEMENT IN DRUG DELIVERY 233, 248-50 (E. Touitou & B. Barry eds., 2007) Download |
Aug 22, 2018 | 2009 | | Esclim Product Label Download |
Aug 22, 2018 | 2008 | | K. Brain & R. Chilcott, Physicochemical Factors Affecting Skin Absorption, in PRINCIPLES AND PRACTICE OF SKIN TOXICOLOGY 83-92 (R. Chilcott and S. Price eds., 2008) Download |
Aug 22, 2018 | 2007 | | A. Williams & B. Barry, Urea analogues in propylene glycol as penetration enhancers in human skin, 36 INT'L J. PHARMACEUTICS 43-50 (1989) Download |
Aug 22, 2018 | 2006 | | B. Barry, Transdermal Drug Delivery, in AULTON'S PHARMACEUTICS ¿¿¿ THE DESIGN AND MANUFACTURE OF MEDICINES 565, 571-72, 577 (M. Aulton ed., 3d ed. 2007) Download |
Aug 22, 2018 | 2005 | | J. Hadgraft, Passive enhancement strategies in topical and transdermal drug delivery, 184 INT'L J. PHARMACEUTICS 1-6 (1999) Download |
Aug 22, 2018 | 2004 | | J. Hadgraft and R. Guy, Feasibility Assessment in Topical and Transdermal Delivery, in TRANSDERMAL DRUG DELIVERY 3-4 (R. Guy & J. Hadgraft eds., 2d ed. 2003) Download |
Aug 22, 2018 | 2003 | | Minivelle¿¿ Product Label Download |
Aug 22, 2018 | 2002 | | Curriculum Vitae of Dr. Adrian C. Williams Download |
Aug 22, 2018 | 2001 | | Declaration of Dr. Adrian C. Williams Download |
May 18, 2018 | 1042 | | EX1042 DE10012908 Download |
May 18, 2018 | 1041 | | EX1041 Mantelle Download |
May 18, 2018 | 1040 | | EX1040 Mantelle Download |
May 18, 2018 | 1039 | | EX1039 Benson Download |
May 18, 2018 | 1038 | | EX1038 US 9,724,310 File History Part 2 of 2 Download |
May 18, 2018 | 1038 | | EX1038 US 9,724,310 File History Part 1 of 2 Download |
May 18, 2018 | 1038 | | EX1038 US 9,724,310 File History Part 1 of 2 Download |
May 18, 2018 | 1037 | | EX1037 US 9,724,310 to Mantelle Download |
May 18, 2018 | 1035 | | EX1035 US 9,730,900 File History Part 1 of 2 Download |
May 18, 2018 | 1035 | | EX1035 US 9,730,900 File History Part 2 of 2 Download |
May 18, 2018 | 1035 | | EX1035 US 9,730,900 File History Part 1 of 2 Download |
May 18, 2018 | 1034 | | EX1034 The Orange Book Download |
May 18, 2018 | 1033 | | EX1033 US Patent No. 6,024,976 to Miranda Download |
May 18, 2018 | 1031 | | EX1031 US Patent No. 4,624,665 to Nuwayser Download |
May 18, 2018 | 1030 | | EX1030 US Patent No. 6,638,528 to Kanios Download |
May 18, 2018 | 1028 | | EX1028 US Patent No. 5,603,947 to Wong Download |
May 18, 2018 | 1027 | | EX1027 US Patent No. 5,352,457 to Jenkins Download |
May 18, 2018 | 1026 | | EX1026 Bronaugh Download |
May 18, 2018 | 1025 | | EX1025 van der Bijl Download |
May 18, 2018 | 1024 | | EX1024 Butschhli - Tiny Patch 'Dots' Pharmaceutical Landscape Download |
May 18, 2018 | 1023 | | EX1023 Dinger - Noven Pharmaceuticals, Inc Download |
May 18, 2018 | 1022 | | EX1022 Bucks Download |
May 18, 2018 | 1021 | | EX1021 US Patent No. 5,227,169 to Heiber Download |
May 18, 2018 | 1020 | | EX1020 US Patent No. 6,521,250 to Meconi Download |
May 18, 2018 | 1019 | | EX1019 US Patent No. 6,156,335 to Rovati Download |
May 18, 2018 | 1018 | | EX1018 US Patent No. 5,902,602 to Muller Download |
May 18, 2018 | 1017 | | EX1017 Menostar - Document #5228320A Download |
May 18, 2018 | 1016 | | EX1016 Alora - Document #5210490A Download |
May 18, 2018 | 1015 | | EX1015 Climara - Document #5243107A Download |
May 18, 2018 | 1014 | | EX1014 Ghosh Download |
May 18, 2018 | 1013 | | EX1013 US Patent No. 5,919,477 to Bevan Download |
May 18, 2018 | 1012 | | EX1012 WO 1996003119 to Fotinos Download |
May 18, 2018 | 1011 | | EX1011 US Patnt No. 5,656,286 to Miranda Download |
May 18, 2018 | 1010 | | EX1010 Kim Download |
May 18, 2018 | 1009 | | EX1009 US Patent No. 5,145,682 to Chien Download |
May 18, 2018 | 1008 | | EX1008 Vivelle Label FOI Affidavit and Doc 5210567A Download |
May 18, 2018 | 1007 | | EX1007 US Pat Pub 20060078602 to Kanios Download |
May 18, 2018 | 1006 | | EX1006 Vivelle-Dot Label FOI Affidavit and Doc 5236149B Download |
May 18, 2018 | 1005 | | EX1005 US Pat Pub 20030099695 to Mueller Download |
May 18, 2018 | 1004 | | EX1004 U.S. 9,833,419 File History Download |
May 18, 2018 | 1003 | | EX1003 Brain CV Download |
May 18, 2018 | 1002 | | EX1002 Brain Declaration Download |
May 18, 2018 | 1001 | | EX1001 U.S. Patent No. 9,833,419 to Mantelle Download |
Nov 16, 2018 | 14 | | Notice of Refund Download |
Oct 26, 2018 | 13 | | Petitioner's Request for Refund Download |
Sep 28, 2018 | 12 | | Granting Joint Motion to Expunge
37 C.F.R. sec 42.5 Download |
Sep 26, 2018 | 11 | | Joint Motion to Expunge Exhibit 2025 Under 37 C.F.R. Section 42.56 Download |
Sep 10, 2018 | 10 | | Decision Granting Joint Motion to Terminate
Due to Settlement Prior to Institution Download |
Sep 5, 2018 | 9 | | Patent Owner's Updated Exhibit List as of September 5, 2018 Download |
Sep 5, 2018 | 8 | | Joint Request to Treat Binding Term Sheet (EX2025) as Business Confidential Information Download |
Sep 5, 2018 | 7 | | Joint Motion to Terminate Proceedings Download |
Aug 22, 2018 | 6 | | Patent Owner Preliminary Response Download |
Jun 28, 2018 | 5 | | Noven Pharmaceuticals, Inc.'s First Updated Mandatory Notice Under 37 C.F.R. Section 42.8 Download |
Jun 7, 2018 | 4 | | Patent Owner Mandatory Notices Download |
May 23, 2018 | 3 | | Notice of Accord Filing Date Download |
May 18, 2018 | 2 | | Petition for Inter Partes Review of US 9,833,419 Download |
May 18, 2018 | 1 | | Petitioner's Power of Attorney Download |